Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion
The latest round of funding was led by Patient Square Capital and included participation from EDBI, PS Capital, Alafi Capital, and NRW.BANK, as well as other existing investors.
